1)Sung JJ, Lau JY, Goh KL, et al;Asia Pacific Working Group on Colorectal C:Increasing incidence of colorectal cancer in Asia:implications for screening. Lancet Oncol 6:871-876, 2005
2)Alberts SR, Horvath WL, Sternfeld WC, et al:Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer:a North Central Cancer Treatment Group phase II study. J Clin Oncol 23:9243-9249, 2005
3)Nordlinger B, Van Cutsem E, Rougier P, et al:Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group. Eur J Cancer 43:2037-2045, 2007
4)Van den Eynde M, Hendlisz A:Treatment of colorectal liver metastases:a review. Rev Recent Clin Trials 4:56-62, 2009
5)Adam R, De Gramont A, Figueras J, et al:The oncosurgery approach to managing liver metastases from colorectal cancer:a multidisciplinary international consensus. Oncologist 17:1225-1239, 2012
6)Spolverato G, Ejaz A, Azad N, et al:Surgery for colorectal liver metastases:The evolution of determining prognosis. World J Gastrointest Oncol 5:207-221, 2013
7)Abdalla EK, Vauthey JN:Improved survival after resection of colorectal liver metastases. J Clin Oncol 24:2679;author reply 2680-2671, 2006
8)Karoui M, Vigano L, Goyer P, et al:Combined first-stage hepatectomy and colorectal resection in a two-stage hepatectomy strategy for bilobar synchronous liver metastases. Br J Surg 97:1354-1362, 2010
9)Tsim N, Healey AJ, Frampton AE, et al:Two-stage resection for bilobar colorectal liver metastases:R0 resection is the key. Ann Surg Oncol 18:1939-1946, 2011
10)Homayounfar K, Bleckmann A, Conradi LC, et al:Bilobar spreading of colorectal liver metastases does not significantly affect survival after R0 resection in the era of interdisciplinary multimodal treatment. Int J Colorectal Dis 27:1359-1367, 2012
11)Schnitzbauer AA, Lang SA, Goessmann H, et al:Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 255:405-414, 2012
12)Kokudo N, Tada K, Seki M, et al:Anatomical major resection versus nonanatomical limited resection for liver metastases from colorectal carcinoma. Am J Surg 181:153-159, 2001
13)Liu W, Sun Y, Zhang L, et al:Negative surgical margin improved long-term survival of colorectal cancer liver metastases after hepatic resection:a systematic review and meta-analysis. Int J Colorectal Dis 30:1365-1373, 2015
14)Andreou A, Aloia TA, Brouquet A, et al:Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy. Ann Surg 257:1079-1088, 2013
15)de Haas RJ, Wicherts DA, Flores E, et al:R1 resection by necessity for colorectal liver metastases:is it still a contraindication to surgery? Ann Surg 248:626-637, 2008
16)Makuuchi M, Thai BL, Takayasu K, et al:Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma:a preliminary report. Surgery 107:521-527, 1990
17)Abulkhir A, Limongelli P, Healey AJ, et al:Preoperative portal vein embolization for major liver resection:a meta-analysis. Ann Surg 247:49-57, 2008
18)de Graaf W, van Lienden KP, van den Esschert JW, et al:Increase in future remnant liver function after preoperative portal vein embolization. Br J Surg 98:825-834, 2011
19)Wicherts DA, de Haas RJ, Salloum C, et al:Repeat hepatectomy for recurrent colorectal metastases. Br J Surg 100:808-818, 2013
20)Kulik U, Bektas H, Klempnauer J, et al:Repeat liver resection for colorectal metastases. Br J Surg 100:926-932, 2013
21)Takahashi M, Hasegawa K, Oba M, et al:Repeat resection leads to long-term survival:analysis of 10-year follow-up of patients with colorectal liver metastases. Am J Surg 210:904-910, 2015
22)Oba M, Hasegawa K, Matsuyama Y, et al:Discrepancy between recurrence-free survival and overall survival in patients with resectable colorectal liver metastases:a potential surrogate endpoint for time to surgical failure. Ann Surg Oncol 21:1817-1824, 2014
23)Ambiru S, Miyazaki M, Ito H, et al:Resection of hepatic and pulmonary metastases in patients with colorectal carcinoma. Cancer 82:274-278, 1998
24)Hwang M, Jayakrishnan TT, Green DE, et al:Systematic review of outcomes of patients undergoing resection for colorectal liver metastases in the setting of extra hepatic disease. Eur J Cancer 50:1747-1757, 2014
25)Sourrouille I, Mordant P, Maggiori L, et al:Long-term survival after hepatic and pulmonary resection of colorectal cancer metastases. J Surg Oncol 108:220-224, 2013
26)Tsukamoto S, Kinugasa Y, Yamaguchi T, et al:Survival after resection of liver and lung colorectal metastases in the era of modern multidisciplinary therapy. Int J Colorectal Dis 29:81-87, 2014
27)Matsui T, Kitamura T, Ozawa H, et al:Analysis of treatment that includes both hepatic and pulmonary resections for colorectal metastases. Surg Today 44:702-711, 2014
28)Kamiyoshihara M, Igai H, Kawatani N, et al:Lung metastasectomy for postoperative colorectal cancer in patients with a history of hepatic metastasis. Gen Thorac Cardiovasc Surg 62:314-320, 2014
29)Mise Y, Kopetz S, Mehran RJ, et al:Is complete liver resection without resection of synchronous lung metastases justified? Ann Surg Oncol 22:1585-1592, 2015
30)Dave RV, Pathak S, White AD, et al:Outcome after liver resection in patients presenting with simultaneous hepatopulmonary colorectal metastases. Br J Surg 102:261-268, 2015
31)Andres A, Mentha G, Adam R, et al:Surgical management of patients with colorectal cancer and simultaneous liver and lung metastases. Br J Surg 102:691-699, 2015
32)Malde DJ, Khan A, Prasad KR, et al:Inferior vena cava resection with hepatectomy:challenging but justified. HPB(Oxford)13:802-810, 2011
33)Miyazaki M, Ito H, Nakagawa K, et al:Aggressive surgical resection for hepatic metastases involving the inferior vena cava. Am J Surg 177:294-298, 1999
34)Yoshidome H, Takeuchi D, Ito H, et al:Should the inferior vena cava be reconstructed after resection for malignant tumors? Am J Surg 189:419-424, 2005
35)Yoshidome H, Kimura F, Shimizu H, et al:Interval period tumor progression:does delayed hepatectomy detect occult metastases in synchronous colorectal liver metastases? J Gastrointest Surg 12:1391-1398, 2008
36)Folprecht G, Gruenberger T, Bechstein WO, et al:Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab:the CELIM randomised phase 2 trial. Lancet Oncol 11:38-47, 2010